MB Pharmaceutics SRL
MB Pharmaceutics reported total assets of 57,363 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of MB Pharmaceutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MB Pharmaceutics's annual accounts
| 2025 | |
|---|---|
| Net result | 44,708 € |
| Equity | 47,708 € |
| Cash | 32,222 € |
| EBITDA | 61,131 € |
| Total assets | 57,363 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
MB Pharmaceutics's financial analysis
- Solvency83.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MB Pharmaceutics
MB Pharmaceutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.359.169
- VAT number
- BE1016359169
- Peppol
- Registered · 0208:1016359169 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Nov 2024
- Registered office
- 3770 Riemst
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MB Pharmaceutics (SRL) has been based in Riemst since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 44,708 € and equity of 47,708 €; its revenue is not published. Its solvency stands at 83.2%, above the median of its sector (44.2%).
Companies similar to MB Pharmaceutics
Companies in the same business, of comparable size and area, outside its group.
- TAM Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 63,040 €
- NZpharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 74,203 €
- L.V. Farma Retail sale of pharmaceutical products Hasselt · balance sheet 83,799 €
- Apotheker Laura Spiritus Retail sale of pharmaceutical products Linter · balance sheet 62,639 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- Pharmacie Marievoet Retail sale of pharmaceutical products Auderghem · balance sheet 60,288 €
- Manon De Marez Retail sale of pharmaceutical products Herent · balance sheet 85,130 €
Frequently asked questions about MB Pharmaceutics
What is the revenue of MB Pharmaceutics?
MB Pharmaceutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MB Pharmaceutics?
In Belgium, the VAT number is the company number prefixed with BE: BE1016359169 for MB Pharmaceutics, if the company is VAT-registered. Its company number (CBE) is 1016.359.169.
Where is the registered office of MB Pharmaceutics?
According to the CBE register, the registered office of MB Pharmaceutics is in 3770 Riemst.
What is the equity of MB Pharmaceutics?
At the close of the 2025 financial year, the equity of MB Pharmaceutics amounts to 47,708 €, a solvency of 83.2% of total assets.
Who manages MB Pharmaceutics?
The register lists 1 active mandates at MB Pharmaceutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MB Pharmaceutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →